![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SET |
Gene summary for SET |
![]() |
Gene information | Species | Human | Gene symbol | SET | Gene ID | 6418 |
Gene name | SET nuclear proto-oncogene | |
Gene Alias | 2PP2A | |
Cytomap | 9q34.11 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | Q01105 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
6418 | SET | GSM4909281 | Human | Breast | IDC | 1.19e-12 | 4.38e-01 | 0.21 |
6418 | SET | GSM4909282 | Human | Breast | IDC | 5.84e-06 | 2.65e-01 | -0.0288 |
6418 | SET | GSM4909286 | Human | Breast | IDC | 1.21e-04 | 2.05e-01 | 0.1081 |
6418 | SET | GSM4909288 | Human | Breast | IDC | 4.01e-02 | 8.44e-02 | 0.0988 |
6418 | SET | GSM4909290 | Human | Breast | IDC | 1.06e-06 | 3.80e-01 | 0.2096 |
6418 | SET | GSM4909293 | Human | Breast | IDC | 3.04e-10 | 3.72e-01 | 0.1581 |
6418 | SET | GSM4909294 | Human | Breast | IDC | 1.30e-17 | 2.92e-01 | 0.2022 |
6418 | SET | GSM4909296 | Human | Breast | IDC | 3.02e-15 | -3.98e-01 | 0.1524 |
6418 | SET | GSM4909297 | Human | Breast | IDC | 1.76e-25 | 2.22e-01 | 0.1517 |
6418 | SET | GSM4909306 | Human | Breast | IDC | 7.23e-03 | -2.71e-01 | 0.1564 |
6418 | SET | GSM4909309 | Human | Breast | IDC | 2.00e-02 | -2.24e-01 | 0.0483 |
6418 | SET | GSM4909311 | Human | Breast | IDC | 3.37e-49 | -5.41e-01 | 0.1534 |
6418 | SET | GSM4909312 | Human | Breast | IDC | 1.00e-09 | -2.43e-01 | 0.1552 |
6418 | SET | GSM4909317 | Human | Breast | IDC | 1.36e-02 | 2.79e-01 | 0.1355 |
6418 | SET | GSM4909318 | Human | Breast | IDC | 4.71e-08 | 4.81e-01 | 0.2031 |
6418 | SET | GSM4909319 | Human | Breast | IDC | 1.16e-58 | -8.01e-01 | 0.1563 |
6418 | SET | GSM4909320 | Human | Breast | IDC | 5.01e-11 | -7.26e-01 | 0.1575 |
6418 | SET | GSM4909321 | Human | Breast | IDC | 1.85e-12 | -3.31e-01 | 0.1559 |
6418 | SET | brca10 | Human | Breast | Precancer | 1.12e-11 | -5.22e-01 | -0.0029 |
6418 | SET | M2 | Human | Breast | IDC | 7.97e-12 | 4.74e-01 | 0.21 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:005140216 | Prostate | Tumor | neuron apoptotic process | 63/3246 | 246/18723 | 6.56e-04 | 4.66e-03 | 63 |
GO:001839311 | Prostate | Tumor | internal peptidyl-lysine acetylation | 44/3246 | 158/18723 | 6.58e-04 | 4.66e-03 | 44 |
GO:003298614 | Prostate | Tumor | protein-DNA complex disassembly | 10/3246 | 20/18723 | 8.21e-04 | 5.54e-03 | 10 |
GO:003496812 | Prostate | Tumor | histone lysine methylation | 34/3246 | 115/18723 | 8.31e-04 | 5.60e-03 | 34 |
GO:000647511 | Prostate | Tumor | internal protein amino acid acetylation | 44/3246 | 160/18723 | 8.75e-04 | 5.87e-03 | 44 |
GO:001402012 | Prostate | Tumor | primary neural tube formation | 29/3246 | 94/18723 | 9.27e-04 | 6.10e-03 | 29 |
GO:190285013 | Prostate | Tumor | microtubule cytoskeleton organization involved in mitosis | 41/3246 | 147/18723 | 9.53e-04 | 6.20e-03 | 41 |
GO:00017061 | Prostate | Tumor | endoderm formation | 19/3246 | 54/18723 | 1.24e-03 | 7.82e-03 | 19 |
GO:000184312 | Prostate | Tumor | neural tube closure | 27/3246 | 88/18723 | 1.50e-03 | 9.25e-03 | 27 |
GO:000633811 | Prostate | Tumor | chromatin remodeling | 63/3246 | 255/18723 | 1.73e-03 | 1.02e-02 | 63 |
GO:006060612 | Prostate | Tumor | tube closure | 27/3246 | 89/18723 | 1.80e-03 | 1.06e-02 | 27 |
GO:002191512 | Prostate | Tumor | neural tube development | 41/3246 | 152/18723 | 1.91e-03 | 1.12e-02 | 41 |
GO:003239212 | Prostate | Tumor | DNA geometric change | 27/3246 | 90/18723 | 2.15e-03 | 1.22e-02 | 27 |
GO:003106011 | Prostate | Tumor | regulation of histone methylation | 22/3246 | 69/18723 | 2.31e-03 | 1.30e-02 | 22 |
GO:00327841 | Prostate | Tumor | regulation of DNA-templated transcription, elongation | 18/3246 | 53/18723 | 2.59e-03 | 1.43e-02 | 18 |
GO:004352315 | Prostate | Tumor | regulation of neuron apoptotic process | 53/3246 | 212/18723 | 2.92e-03 | 1.58e-02 | 53 |
GO:003250811 | Prostate | Tumor | DNA duplex unwinding | 25/3246 | 84/18723 | 3.47e-03 | 1.79e-02 | 25 |
GO:003090012 | Prostate | Tumor | forebrain development | 86/3246 | 379/18723 | 4.22e-03 | 2.11e-02 | 86 |
GO:001097611 | Prostate | Tumor | positive regulation of neuron projection development | 42/3246 | 163/18723 | 4.24e-03 | 2.12e-02 | 42 |
GO:00508901 | Prostate | Tumor | cognition | 69/3246 | 296/18723 | 5.03e-03 | 2.45e-02 | 69 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SET | SNV | Missense_Mutation | rs142648600 | c.548N>T | p.Ser183Leu | p.S183L | Q01105 | protein_coding | tolerated(0.16) | benign(0.11) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SET | SNV | Missense_Mutation | novel | c.270N>C | p.Lys90Asn | p.K90N | Q01105 | protein_coding | tolerated(0.05) | benign(0.16) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
SET | SNV | Missense_Mutation | c.195N>C | p.Glu65Asp | p.E65D | Q01105 | protein_coding | deleterious(0.01) | possibly_damaging(0.651) | TCGA-C5-A1MH-01 | Cervix | cervical & endocervical cancer | Female | >=65 | III/IV | Chemotherapy | cisplatin | PD | |
SET | SNV | Missense_Mutation | novel | c.469N>A | p.His157Asn | p.H157N | Q01105 | protein_coding | tolerated(0.06) | benign(0.208) | TCGA-HM-A4S6-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Chemotherapy | cisplatin | CR |
SET | SNV | Missense_Mutation | c.229C>T | p.Arg77Cys | p.R77C | Q01105 | protein_coding | tolerated(0.11) | benign(0.444) | TCGA-CM-4746-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
SET | SNV | Missense_Mutation | c.572G>A | p.Ser191Asn | p.S191N | Q01105 | protein_coding | tolerated(0.16) | benign(0.029) | TCGA-CM-4746-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
SET | SNV | Missense_Mutation | c.260N>C | p.Leu87Ser | p.L87S | Q01105 | protein_coding | deleterious(0) | probably_damaging(0.974) | TCGA-F4-6570-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
SET | SNV | Missense_Mutation | c.508N>A | p.Glu170Lys | p.E170K | Q01105 | protein_coding | tolerated(0.18) | benign(0.086) | TCGA-G4-6628-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
SET | deletion | Frame_Shift_Del | c.273delN | p.Pro92GlnfsTer5 | p.P92Qfs*5 | Q01105 | protein_coding | TCGA-CM-5862-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |||
SET | SNV | Missense_Mutation | novel | c.161N>C | p.Glu54Ala | p.E54A | Q01105 | protein_coding | tolerated(0.06) | possibly_damaging(0.893) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |